Celsion Corporation to Present Preliminary Results of Its Breast Cancer Study at the 9th International Congress on Hyperthermic Oncology.Business Editors/Health/Medical Writers COLUMBIA, Md.--(BUSINESS WIRE)--April 15, 2004 CELSION CORPORATION (AMEX AMEX See: American Stock Exchange :CLN) today announced that the Massachusetts Institute of Technology's (MIT) News Office issued a release that Preliminary results of Celsion's breast cancer study are to be presented the week of April 20, 2004, at the 9th International Congress on Hyperthermic Oncology in St. Louis, Missouri. The preliminary data will be presented by Dr. William C. Dooley, Director of Surgical Oncology at The University of Oklahoma University of Oklahoma, abbreviated OU, is a coeducational public research university located in the U.S. state of Oklahoma. Founded in 1890, it existed in Oklahoma Territory near Indian Territory 17 years before the two became the state of Oklahoma. Breast Institute and principal investigator of the ongoing study. "One of the primary objectives of this randomized study is to demonstrate that heat can affect and kill early-stage breast cancer cells prior to surgery," said Dr. Dooley, "With this focused heat treatment, it may be possible for the surgeon to provide better margins for the patient and possibly avoid additional treatment procedures and avoid recurrence of the cancer." Since October 2002, 90 women with early stage breast cancer have enrolled in the study, in which microwave energy focused externally on the breast is delivered to tumors prior to lumpectomy. The goal is to use focused heat to kill tumor cells and reduce additional surgery. The current results are based on the 60 women who have completed treatment. Preliminary results indicate that in the Thermotherapy plus Surgery arm, 25 of 30 (83.3%) patients had negative (clean) margins, whereas, in the Surgery Alone Arm, 24 of 34 (70.6%) patients had negative (clean) margins. Thus, preliminary results indicate that women with early-stage breast cancer who received the MIT treatment prior to lumpectomy had a reduction in the incidence rate of cancer cells found close to the surgical margins. The MIT release can be accessed at http://web.mit.edu/newsoffice/nr/ Treating cancer with heat is not a new idea, but "researchers were having trouble using it to treat tumors deep within the body," said Dr. Alan Fenn, a senior staff member at MIT Lincoln Laboratory and inventor of the technique. This breast cancer treatment This article or section recently underwent a major revision or rewrite and needs further review. You can help! The mainstay of breast cancer treatment is surgery when the tumor is localized, with possible adjuvant hormonal therapy (with tamoxifen or an aromatase is based on MIT research originally aimed at detecting space-borne missiles. Previous Phase II, dose-escalation, results of the breast cancer heat treatment were reported in the February 2004 issue of the Annals of Surgical Oncology. The data for breast cancer patients treated in the dose-escalation trial were submitted to the U.S. Food and Drug Administration to support allowance to proceed with the randomized trial currently underway. Celsion Corporation exclusively licenses the focused microwave thermotherapy technology from MIT. The company has developed the clinical thermotherapy system and is funding the current clinical studies. The Department of the Air Force The executive part of the Department of the Air Force at the seat of government and all field headquarters, forces, Reserve Components, installations, activities, and functions under the control or supervision of the Secretary of the Air Force. Also called DAF. See also Military Department. funded the original MIT Lincoln Laboratory research by Fenn. Forward-looking statements in this letter are made pursuant to the "safe harbor" provisions of the Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995. Readers are cautioned that such forward-looking statements involve risks and uncertainties including, without limitation, unforeseen changes in the course of research and development activities and in clinical trials by us and by others; possible acquisitions of other technologies, assets or businesses; possible actions by customers, suppliers, competitors, and regulatory authorities; and other risks detailed from time to time in the Company's periodic reports filed with the Securities and Exchange Commission. About Celsion: Celsion Corporation, based in Columbia, Maryland, is a biotechnology company dedicated to the development and commercialization of treatment systems for cancer and other diseases using focused-heat energy, either administered alone, or in combination with other therapeutic devices, heat activated genes and heat activated drugs. In January 2003, Celsion entered into a strategic alliance with Boston Scientific Corporation (NYSE NYSE See: New York Stock Exchange :BSX) in which Boston Scientific will initially distribute the Prolieve Thermodilatation system worldwide. Boston Scientific currently owns approximately 7% of Celsion's outstanding stock. Celsion has research, license or commercialization agreements with leading institutions such as the National Institute of Health, Duke University Medical Center, Massachusetts Institute of Technology Massachusetts Institute of Technology, at Cambridge; coeducational; chartered 1861, opened 1865 in Boston, moved 1916. It has long been recognized as an outstanding technological institute and its Sloan School of Management has notable programs in business, , Harbor UCLA Medical Center UCLA Medical Center is a hospital located on the campus of the University of California, Los Angeles in Los Angeles, California. It is rated as one of the top three hospitals in the United States and is the top hospital on the West Coast according to US News & World Report. , Montefiore Medical Center Montefiore Medical Center, in the Bronx, New York, is the university hospital of the Albert Einstein College of Medicine. The hospital, named after Moses Montefiore, is one of the 50 largest employers in New York State [1]. and Memorial Sloan-Kettering Cancer Center The Memorial Sloan-Kettering Cancer Center (MSKCC) in New York City is a cancer treatment and research institution founded in 1884 as the New York Cancer Hospital. The main campus is located at 1275 York Avenue, between 67th and 68th Streets, with other locations in New in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , Roswell Park Cancer Institute The Roswell Park Cancer Institute is a cancer research and treatment center located in Buffalo, New York. Founded in 1898 by Dr. Roswell Park, it was the first dedicated medical facility for cancer treatment and research in the United States. in Buffalo, New York, and Duke University. For more information on Celsion, visit our website: www.celsion.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion